Get started
Author

Takashi Hatanaka

Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
2014 · Naoto Terami, Daisuke Ogawa, et al. · PLoS ONE · 345
Inhibition of SGLT2 alleviates diabetic nephropathy by suppressing high glucose‐induced oxidative stress in type 1 diabetic mice
2016 · Takashi Hatanaka, Daisuke Ogawa, et al. · Pharmacology Research & Perspectives · 91
PDF
Expression of the bovine heart mitochondrial ADP/ATP carrier in yeast mitochondria: significantly enhanced expression by replacement of the N-terminal region of the bovine carrier by the corresponding regions of the yeast carriers
1999 · Mitsuru Hashimoto, Yasuo Shinohara, et al. · Biochimica et Biophysica Acta (BBA) - Bioenergetics · 71
Increased Expression of CYR61, an Extracellular Matrix Signaling Protein, in Human Benign Prostatic Hyperplasia and Its Regulation by Lysophosphatidic Acid
2004 · Shinji Sakamoto, Masahiro Yokoyama, et al. · Endocrinology · 51
Functional Expression of the Tandem-Repeated Homodimer of the Mitochondrial ADP/ATP Carrier in Saccharomyces cerevisiae
1999 · Takashi Hatanaka, Mitsuru Hashimoto, et al. · Biochemical and Biophysical Research Communications · 39
Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-induced diabetic mice
2013 · Hiromi Tachibana, Daisuke Ogawa, et al. · American Journal of Physiology-Renal Physiology · 28
Characterization of Loops of the Yeast Mitochondrial ADP/ATP Carrier Facing the Cytosol by Site-Directed Mutagenesis
2001 · Takashi Hatanaka, Yoshitaka Kihira, et al. · Biochemical and Biophysical Research Communications · 24
Nuclear Hormone Receptor Expression in Mouse Kidney and Renal Cell Lines
2014 · Daisuke Ogawa, Jun Eguchi, et al. · PLoS ONE · 15
PDF
Significant Expression of Functional Human Type 1 Mitochondrial ADP/ATP Carrier in Yeast Mitochondria.
2001 · Takashi HATANAKA, Yukiyo TAKEMOTO, et al. · Biological and Pharmaceutical Bulletin · 14
PDF
A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope
2024 · Satoshi Miyamoto, Hiddo J.L. Heerspink, et al. · Kidney International · 13
PDF
Significant Effect of the N-terminal Region of the Mitochondrial ADP/ATP Carrier on Its Efficient Expression in Yeast Mitochondria
2001 · Takashi Hatanaka, Mitsuru Hashimoto, et al. · Journal of Biological Chemistry · 11
PDF
Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE study
2022 · Satoshi Miyamoto, Hiddo J. L. Heerspink, et al. · Diabetes Obesity and Metabolism · 5
Cystatin C Confirms the Canagliflozin eGFR Slope Benefit in CANPIONE
2026 · Satoshi Miyamoto, Hiddo J.L. Heerspink, et al. · Kidney International Reports · 1
PDF
The effect of switching treatment from insulin or voglibose to DPP-4 inhibitor teneligliptin in dialysis patients with type 2 diabetes
2014 · Takashi Hatanaka · Therapeutic research
Works count: 14
Citation count: 708
H-index: 11
I10-index: 11
Year
Topic
Type